2nd Quarter - Report — NATIONAL KIDNEY FOUNDATION for NATIONAL KIDNEY FOUNDATION (2018)

Firm

NATIONAL KIDNEY FOUNDATION

Client

NATIONAL KIDNEY FOUNDATION

Income

—

Expenses

$100,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY 2019 Appropriations for the Department of Health and Human Services (NIH, CDC, HRSA); Food and Drug Administration; Department of Veterans Affairs, Indian Health Service, Department of Defense

Lobbyist	Covered position, as disclosed
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Labor, Dept of (DOL); Agency for Healthcare Research & Quality (AHRQ); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES

Health Issues HCR

Implementation and Management of the Patient Protection and Affordable Care Act Repeal and Replace of ACA Initiatives to increase and facilitate organ donation and transplantation, including H.R.1270 (Living Donor Protection Act) and build support for a Senate companion bill Support for H.R. 2644 and S. 1890, Chronic Kidney Disease Improvement in Research and Treatment Act of 2017 Participation in the HHS Million Hearts initiative Participation in HHS KidneyX initiative

Lobbyist	Covered position, as disclosed
ANDREW W. FULLERTON New	—
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH); SENATE; Agency for Healthcare Research & Quality (AHRQ); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1270 (115th), S. 1890 (115th), H.R. 2644 (115th)

Medicare/Medicaid MMM

Initiatives to support early detection and management of Chronic Kidney Disease (H.R. 3867)and build support for a Senate companion bill Proposed Alternative Payment Model for Chronic Kidney Disease care Increased utilization of home kidney dialysis Medicare coverage of immunosuppressive drugs for kidney transplant recipients Increased utilization of kidney discards for transplantation

Lobbyist	Covered position, as disclosed
ANDREW W. FULLERTON New	—
TONYA SAFFER	—
TROY ZIMMERMAN	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); HOUSE OF REPRESENTATIVES; SENATE; Labor, Dept of (DOL); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC)

Bills named: H.R. 3867 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.